MEK2 (Protein|Antibody|cDNA Clone|ELISA Kit)

All MEK2 reagents are produced in house and quality controlled, including 2 MEK2 Antibody, 30 MEK2 Gene, 1 MEK2 Lysate, 1 MEK2 Protein, 2 MEK2 qPCR. All MEK2 reagents are ready to use.

Recombinant MEK2 proteins are expressed by Baculovirus-Insect Cells with fusion tags as N-GST.

MEK2 antibodies are validated with different applications, which are ELISA.

MEK2 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each MEK2 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

MEK2 Protein (1)

Species

MEK2 Protein, Human, Recombinant (GST Tag)

10678-H09B

Expression host: Baculovirus-Insect Cells

Human MEK2/MAP2K2/MKK2 Protein 9006
Go

MEK2 Antibody (2)

Application
Clonality
Host

Anti-MEK2 Antibody

10678-MM01

Specificity: Human

Application: ELISA

Clonality: MAb

Anti-MEK2 Antibody

10678-RP01

Specificity: Human

Application: ELISA

Clonality: PAb

Go

MEK2 cDNA Clone (30)

Human
Mouse

MEK2 qPCR Primer (2)

MEK2 Lysate (1)

Dual specificity mitogen-activated protein kinase kinase 2, also known as MAP kinase kinase 2, MAPKK2, ERK activator kinase 2, MAPK / ERK kinase 2, MEK2 and MAP2K2, is a member of the protein kinase superfamily, STE Ser/Thr protein kinase family and MAP kinase kinase subfamily. MAP2K2 / MEK2 contains one protein kinase domain. MEK1 and MEK2 (also known as MAP2K1 and MAP2K2, respectively) are evolutionarily conserved, dual-specificity kinases that mediate Erk1 and Erk2 activation during adhesion and growth factor signaling. MAP2K1 / MEK1 is a crucial modulator of Mek and Erk signaling and have potential implications for the role of MEK1 and MEK2 in tumorigenesis. MAP2K2 / MEK2 catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. It also activates the ERK1 and ERK2 MAP kinases. Defects in MAP2K2 are a cause of cardiofaciocutaneous syndrome (CFC syndrome) which is characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy.Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy
Protein
Antibody
Gene
qPCR
Lysate
Close